Jefferies Group LLC lifted its stake in shares of PerkinElmer, Inc. (NYSE:PKI) by 464.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 25,586 shares of the medical research company’s stock after buying an additional 21,053 shares during the quarter. Jefferies Group LLC’s holdings in PerkinElmer were worth $1,871,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. American Century Companies Inc. acquired a new position in PerkinElmer in the fourth quarter valued at approximately $61,260,000. Robecosam AG boosted its holdings in PerkinElmer by 165.7% in the third quarter. Robecosam AG now owns 477,167 shares of the medical research company’s stock valued at $32,610,000 after purchasing an additional 297,595 shares in the last quarter. BlackRock Inc. boosted its holdings in PerkinElmer by 3.2% in the fourth quarter. BlackRock Inc. now owns 6,260,111 shares of the medical research company’s stock valued at $457,740,000 after purchasing an additional 195,851 shares in the last quarter. AXA acquired a new position in PerkinElmer in the fourth quarter valued at approximately $10,712,000. Finally, Russell Investments Group Ltd. boosted its holdings in PerkinElmer by 135.0% in the third quarter. Russell Investments Group Ltd. now owns 250,350 shares of the medical research company’s stock valued at $17,268,000 after purchasing an additional 143,822 shares in the last quarter. 91.94% of the stock is owned by institutional investors and hedge funds.
Shares of PerkinElmer, Inc. (PKI) opened at $78.08 on Wednesday. The company has a quick ratio of 0.89, a current ratio of 1.26 and a debt-to-equity ratio of 0.71. PerkinElmer, Inc. has a 52 week low of $55.41 and a 52 week high of $84.49. The firm has a market capitalization of $8,705.53, a P/E ratio of 26.98, a price-to-earnings-growth ratio of 1.82 and a beta of 0.79.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Shareholders of record on Friday, April 13th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date is Thursday, April 12th. PerkinElmer’s dividend payout ratio is currently 10.61%.
In other PerkinElmer news, insider Andrew Okun sold 2,273 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $77.86, for a total value of $176,975.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Frank Anders Wilson sold 103,656 shares of the business’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $73.94, for a total value of $7,664,324.64. Following the completion of the sale, the insider now owns 93,624 shares of the company’s stock, valued at approximately $6,922,558.56. The disclosure for this sale can be found here. In the last quarter, insiders sold 120,933 shares of company stock valued at $8,929,583. 2.20% of the stock is owned by company insiders.
A number of brokerages recently issued reports on PKI. Bank of America raised PerkinElmer from an “underperform” rating to a “neutral” rating and set a $78.00 price target for the company in a report on Tuesday, December 19th. Barclays upped their price target on PerkinElmer from $69.00 to $73.00 and gave the company an “underweight” rating in a report on Friday, January 26th. ValuEngine downgraded PerkinElmer from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Zacks Investment Research raised PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price target for the company in a report on Monday, January 8th. Finally, Cowen reaffirmed a “hold” rating and issued a $84.00 price target on shares of PerkinElmer in a report on Friday, January 26th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $76.85.
COPYRIGHT VIOLATION NOTICE: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/03/14/jefferies-group-llc-has-1-87-million-stake-in-perkinelmer-inc-pki.html.
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.